This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Indiana University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in Retinal Vascular Disease Treatment by Inventor Xiao Fu
Introduction
Xiao Fu is a prominent inventor based in London, GB. She has made significant contributions to the field of ophthalmology, particularly in the treatment and prevention of retinal vascular diseases. Her innovative approach has the potential to improve the quality of life for patients suffering from these conditions.
Latest Patents
Xiao Fu holds a patent for her work titled "Treatment and prevention of retinal vascular disease by photocoagulation." This patent relates to methods for treating or preventing retinal vascular disease through photocoagulation. More specifically, it describes an improved technique for the placement of retinal burns to prevent the development of hypoxia and the progression of ischemia in retinal tissue, including the macula. The methods can also be employed to prevent potential ischemic tissue damage in diabetic, pre-diabetic, or other patients at risk of ischemic retinal vascular disease.
Career Highlights
Xiao Fu is affiliated with Indiana University, where she continues her research and development in the field of retinal health. Her work has garnered attention for its innovative techniques and potential impact on patient care.
Collaborations
Xiao Fu collaborates with esteemed colleagues, including Thomas J Gast and James A Glazier, to further advance her research and innovations in retinal disease treatment.
Conclusion
Xiao Fu's contributions to the treatment of retinal vascular diseases through her patented methods highlight her role as a leading inventor in the field. Her work not only showcases her innovative spirit but also emphasizes the importance of advancements in medical technology for improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
